NeuroPace (NPCE) Tops Q3 EPS by 9c

NeuroPace (NASDAQ: NPCE) reported Q3 EPS of ($0.11), $0.09 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $24.31 million.

For earnings history and earnings-related data on NeuroPace (NPCE) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• Levi (LEVI) Tops Q2 EPS by 4c, Offers Guidance
• Nocera files to register 7.5 million shares under SEC Form S-3